Optimi Health Corp. (NASDAQ:OPTH) Short Interest Update

Optimi Health Corp. (NASDAQ:OPTH) saw a large decline in short interest in August. As of August 31st, there was short interest totaling 9,806 shares, a decline of 44.5% from the August 15th total of 17,682 shares. Based on an average trading volume of 20,884 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.2% of the company’s stock are short sold.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on OPTH shares. Wall Street Zen raised shares of Optimi Health to a “hold” rating in a research note on Saturday, July 25th. Weiss Ratings upgraded Optimi Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 27th. Finally, Zacks Research raised Optimi Health to a “hold” rating in a research report on Thursday, May 28th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce”.

Optimi Health Stock Performance

Shares of Optimi Health stock remained flat at $4.76 during midday trading on Tuesday. 77,323 shares of the stock were exchanged, compared to its average volume of 98,363. The company has a quick ratio of 0.03, a current ratio of 0.06 and a debt-to-equity ratio of 0.04. Optimi Health has a fifty-two week low of $4.00 and a fifty-two week high of $6.40. The firm’s 50 day moving average is $4.77. The firm has a market capitalization of $27.26 million and a PE ratio of -6.26.

Optimi Health Company Profile

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.